Oct. 7, 2022
Case study
Sponsored by Arctoris
Arctoris is driven by a relentless pursuit to make drug discovery better. An industry where bringing a single drug to …
There are many drug target classes for which unwanted on-target pharmacology limits clinical application. Understanding E3 tissue expression across both …
A key step in the targeted protein degradation (TPD) process is the formation of an induced proximity complex, where a …
In contrast to the discovery of "traditional drugs" such as small molecule inhibitors and most biologics, the development of protein …
Sept. 2, 2022
by Bohdana Sokolova
Biopharma insight
According to the World Health Organisation, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths …
Aug. 24, 2022
by Joseph Pareti
Biopharma insight
AstraZeneca has achieved outstanding results in drug design using large language models applied to SMILES representation of molecules; but what are …
Aug. 18, 2022
by Bohdana Sokolova
Biopharma insight
Development of a novel drug is a tedious process that requires immense investments of resources and time - on average, …
Aug. 17, 2022
by Andrii Buvailo
Interview
Vaxess is a venture capital and Gates Foundation-backed company that is developing vaccine patches. Their mission is to significantly increase …
Aug. 11, 2022
by Natalia Honchar
Biopharma insight
Nanomedicines, as it goes from the name, are nanotechnology-based drugs, used for the treatment, diagnosis or prevention of various diseases. …
Aug. 2, 2022
by Andrii Buvailo
Biopharma insight
Canada has established itself as a rapidly growing global hub for artificial intelligence (AI) innovation and commercialization. This roots deep …
Aug. 1, 2022
by Natalia Honchar
Biopharma insight
Curi Bio, a developer of human stem cell-based platforms for drug discovery, announced the commercial launch of the Mantarray™ platform …
July 28, 2022
by Natalia Honchar
Biopharma insight
Valo Therapeutics Oy (ValoTx), the developer of antigen-coated oncolytic viruses and vaccine vectors as therapeutic vaccines against cancer and infectious …